<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27502482</article-id>
      <article-id pub-id-type="pmc">4977682</article-id>
      <article-id pub-id-type="publisher-id">655</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0655-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of lymphomatosis cerebri mimicking inflammatory diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Murakami</surname>
            <given-names>Takenobu</given-names>
          </name>
          <address>
            <phone>+81-24-547-1248</phone>
            <email>takebou@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshida</surname>
            <given-names>Kenji</given-names>
          </name>
          <address>
            <email>yoshiken@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Segawa</surname>
            <given-names>Mari</given-names>
          </name>
          <address>
            <email>jasmin@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshihara</surname>
            <given-names>Akioh</given-names>
          </name>
          <address>
            <email>akioh@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoshi</surname>
            <given-names>Akihiko</given-names>
          </name>
          <address>
            <email>hoshia@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakamura</surname>
            <given-names>Koichiro</given-names>
          </name>
          <address>
            <email>knaka0325@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ichikawa</surname>
            <given-names>Masahiro</given-names>
          </name>
          <address>
            <email>masamasa@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suzuki</surname>
            <given-names>Osamu</given-names>
          </name>
          <address>
            <email>osuzuki@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yokoyama</surname>
            <given-names>Yuichi</given-names>
          </name>
          <address>
            <email>yokoyama@med.niigata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Toyoshima</surname>
            <given-names>Yasuko</given-names>
          </name>
          <address>
            <email>yasuko@bri.niigata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sugiura</surname>
            <given-names>Yoshihiro</given-names>
          </name>
          <address>
            <email>sugiura@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ito</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <address>
            <email>h-ito@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saito</surname>
            <given-names>Kiyoshi</given-names>
          </name>
          <address>
            <email>kiyoshis@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hashimoto</surname>
            <given-names>Yuko</given-names>
          </name>
          <address>
            <email>ykhykh@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kakita</surname>
            <given-names>Akiyoshi</given-names>
          </name>
          <address>
            <email>kakita@bri.niigata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takahashi</surname>
            <given-names>Hitoshi</given-names>
          </name>
          <address>
            <email>hitoshi@bri.niigata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ugawa</surname>
            <given-names>Yoshikazu</given-names>
          </name>
          <address>
            <email>ugawa@fmu.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology, Fukushima Medical University, 1, Hikarigaoka, Fukushima, 960-1295 Japan </aff>
        <aff id="Aff2"><label>2</label>Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, 1, Hikarigaoka, Fukushima, 960-1295 Japan </aff>
        <aff id="Aff3"><label>3</label>Department of Neurology, Fukushima Red Cross Hospital, 11-31, Iriecho, Fukushima, 960-8530 Japan </aff>
        <aff id="Aff4"><label>4</label>Department of Neurosurgery, Fukushima Medical University, 1, Hikarigaoka, Fukushima, 960-1295 Japan </aff>
        <aff id="Aff5"><label>5</label>Department of Pathology, Fukushima Medical University, 1, Hikarigaoka, Fukushima, 960-1295 Japan </aff>
        <aff id="Aff6"><label>6</label>Department of Pathology, Brain Research Institute, Niigata University, 1-757, Asahimachi-dori, Chuo-ku, Niigata, 951-8585 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>128</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Lymphomatosis cerebri (LC) is a rare subtype of primary central nervous system malignant lymphoma. The typical features of this disease exhibited on magnetic resonance imaging (MRI) without contrast enhancement are similar to those observed with diffuse leukoencephalopathy, mimicking white matter disorders such as encephalitis. Clinical features and examination findings that are suggestive of inflammatory diseases may indeed confound the diagnosis of LC.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 66-year-old woman with continuous fever over a two-month period developed left hemiparesis despite presenting in an alert state with normal cognitive function. Sampling tests showed autoantibodies in the serum and inflammatory changes in the cerebrospinal fluid. The results from an MRI demonstrated multiple non-enhanced brain lesions in the splenium of the corpus callosum and deep white matter. Single photon emission computed tomography revealed increases in blood flow in the basal ganglia, thalamus and brainstem. No systemic malignancies were found. The patient was suspected of having a diagnosis of nonvasculitic autoimmune inflammatory meningoencephalitis and treated with intravenous methylprednisolone pulse therapy. Her fever transiently dropped to within the normal range. However, she had a sudden seizure and a second MRI exhibited infiltrative lesions gradually extending throughout the whole brain. We performed a brain biopsy, and LC was histologically diagnosed. The patient received whole-brain radiation therapy, which diminished the fever and seizures. The patient died one year after the initial onset of fever.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The present case yields an important consideration that brain neoplasms, especially LC, cannot be ruled out, even in cases with clinical characteristics and examinations consistent with inflammatory diseases. Careful follow-up and histological study are vital for the correct diagnosis of LC.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Lymphomatosis cerebri</kwd>
        <kwd>Fever</kwd>
        <kwd>Nonvasculitic autoimmune inflammatory meningoencephalitis</kwd>
        <kwd>Brain biopsy</kwd>
        <kwd>Magnetic resonance imaging</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution> the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology</institution>
          </funding-source>
          <award-id>26860675</award-id>
          <award-id>26461314</award-id>
          <principal-award-recipient>
            <name>
              <surname>Murakami</surname>
              <given-names>Takenobu</given-names>
            </name>
            <name>
              <surname>Hoshi</surname>
              <given-names>Akihiko</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology</institution>
          </funding-source>
          <award-id>15H01563</award-id>
          <award-id>22390181</award-id>
          <principal-award-recipient>
            <name>
              <surname>Murakami</surname>
              <given-names>Takenobu</given-names>
            </name>
            <name>
              <surname>Ugawa</surname>
              <given-names>Yoshikazu</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Takeda Science Foundation</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Kanae Foundation for the Promotion of Medical Science</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Uehara Memorial Foundation</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Novartis Foundation (Japan) for the Promotion of Science</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the SENSHIN Medical Research Foundation</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Primary central nervous system malignant lymphoma (PCNSL) generally forms either a single or multiple isolated, solitary mass lesions in the brain parenchyma. A very rare PCNSL variant, known as lymphomatosis cerebri (LC), presents as the diffuse infiltration of lymphoma cells in gray and white matter without the formation of a cohesive tumor mass [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In this study, we report the case of a patient with continuous fever and multiple brain lesions. Because the patient had autoantibodies with no positive findings of malignancy, she was initially suspected of having a diagnosis of nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM). Because extensive immunotherapy failed to result in symptomatic improvements, we performed a brain biopsy, which revealed diffuse infiltration of lymphoma cells in the brain parenchyma. Thus, a diagnosis of LC was made. We showed that LC could follow a clinical course mimicking inflammatory disease and that careful attention was required to distinguish LC from inflammatory diseases.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 66-year-old woman, who had been healthy with no relevant previous medical history, complained of continuous fever starting two months before initial presentation. She realized weakness on her left extremities and was admitted to a city hospital for evaluation of fever and left hemiparesis. Then, she was transferred to our hospital for further evaluation three weeks later. On examination, her general condition was normal, except for an elevated body temperature (38.0&#xB0; Celsius). No lymph-nodes were palpable. Additionally, she did not complain of Sicca symptoms, night sweats or weight loss. The patient was alert and had normal cognitive function. She had left hemiparesis (grade 4 as measured by the Manual Muscle Strength Testing) with bilateral brisk deep tendon reflexes and extensor plantar responses. Sensory extinction was noted in her left extremities.</p>
      <p>The blood sample tests showed a slightly elevated C-reactive protein level (0.68&#xA0;mg/dl) and erythrocyte sedimentation rate (17&#xA0;mm/h) as well as a high titer of antinuclear antibodies (x1280, speckled pattern). Anti-SS-A and anti-Ro52 antibodies were positive but anti-SS-B antibody was negative. Lip biopsy showed no inflammation. Immunoblotting revealed IgG-k monoclonal gammopathy; however, bone marrow histology showed 10&#xA0;% proliferation of clonal plasma cells without light chain restriction, and Bence-Jones protein was not found. Tumor markers were negative and soluble interleukin-2 receptor (sIL-2R) was within the normal range. Cerebrospinal fluid (CSF) showed slight pleocytosis (11/&#x3BC;l; mature lymphocyte 94&#xA0;%, no atypical cells). However, normal ranges of glucose and protein levels (73&#xA0;mg/dl and 26&#xA0;mg/dl, respectively) were observed. We also observed increments of both the IgG index (1.26) and interleukin 6 (29.4&#xA0;pg/ml) but no increment of sIL-2R.</p>
      <p>Brain magnetic resonance imaging (MRI) exhibited hyperintense signals in the splenium of the corpus callosum and right-hemisphere dominant deep subcortical white matter without contrast enhancements (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a-c</xref>). The brain lesions showed normal concentration patterns of choline, creatine and N-acetyl aspartate using MR spectroscopy. However, <sup>123</sup>I-IMP single photon emission computed tomography (SPECT) demonstrated blood flow increases in the basal ganglia, thalamus and brainstem (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>), and <sup>201</sup>Tl-scintigraphy revealed no abnormal accumulation in any part of the brain. <sup>67</sup>Ga-scintigraphy found no evidence of systemic malignancy.<fig id="Fig1"><label>Fig. 1</label><caption><p>Brain magnetic resonance images and single photon emission computed tomography (SPECT). <bold>a</bold>-<bold>c</bold> Two months after fever onset, fluid-attenuated inversion recovery (FLAIR) images show diffuse high signal intensity in the splenium of the corpus callosum and right-hemisphere dominant subcortical white matters. However, this finding is (<bold>a</bold>) neither exhibited in the temporal lobes nor exhibited in the brainstem (<bold>c</bold>). No contrast enhanced lesions are observed in gadolinium-enhanced T1-weighted images (<bold>b</bold>). <bold>d</bold> SPECT study shows hyperperfusion in the basal ganglia, thalamus and brainstem. (E-H) Axial FLAIR images. Approximately five months after the onset of fever, hyperintensity lesions extended to the frontotemporal lobes, bilaterally (<bold>e</bold>, <bold>f</bold>). Twelve months after the onset of fever, FLAIR images show diffuse progression of infiltrative lesions in the whole brain including the brainstem with systemic brain atrophy (<bold>g</bold>, <bold>h</bold>)</p></caption><graphic xlink:href="12883_2016_655_Fig1_HTML" id="MO1"/></fig></p>
      <p>We tentatively diagnosed the patient as having NAIM associated with anti-SS-A and anti-Ro52 antibodies, as well as monoclonal gammopathy of undetermined significance. She was treated with intravenous methylprednisolone (mPSL) pulse therapy (1&#xA0;g during the course of three days) and her fever transiently ceased. Three months after the onset of fever, she suddenly developed generalized tonic-clonic seizures (GTCS), which remained uncontrolled after the administration of antiepileptic medications. Intravenous immunoglobulin (IVIG) (0.4&#xA0;g/kg in five days) had no beneficial effects. A second brain MRI showed extensive lesions that had developed in the bilateral frontotemporal lobes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e, f</xref>).</p>
      <p>Brain specimens were sampled from the right frontal lobe using a brain biopsy. The histopathological examination showed atypical lymphoid cells with enlarged round nuclei diffusely infiltrating the cortical gray and subcortical white matters. These atypical cells were not cohesive, nor did they form a mass lesion. Perivascular tumor-cell cuffing was partly observed but not conspicuous. No necrosis was present, and mitotic figures were scant in number. Atypical cells were strongly labeled by antibodies for CD20, a B-cell marker. Additional immnunohistochemical studies revealed that tissue was positive for BCL-2, BCL-6 and MUM-1 but negative for CD5 and CD10 (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a-i</xref>). A diagnosis of LC variant of diffuse large B-cell lymphoma, non-germinal center B-cell pattern was made based on these histopathological and immunohistochemical features.<fig id="Fig2"><label>Fig. 2</label><caption><p>Pathological findings of brain biopsy. <bold>a</bold>-<bold>c</bold> Hematoxylin-eosin staining revealed diffuse infiltration of atypical cells in cortical gray (<bold>a</bold>, <bold>b</bold>) and deep white matter (<bold>c</bold>). Lymphoma cells show enlarged round nuclei, thin cytoplasmic rims and occasional nucleoli (arrowheads). Mitotic cells (<italic>arrow</italic>) and reactive astrocytes with eosinophilic cytoplasm (<italic>asterisk</italic>) are identified (<bold>b</bold>). Perivascular infiltration of the atypical cells was partly observed (<bold>d</bold>). Immunohistochemical studies revealed the infiltration of CD20 positive cells in the parenchyma (<bold>e</bold>, <bold>f</bold>) and numerous MIB-1 positive cells (<bold>g</bold>). BCL-6 and MUM-1 immnunostainings highlight a non-germinal center B-cell pattern (<bold>h</bold>, <bold>i</bold>)</p></caption><graphic xlink:href="12883_2016_655_Fig2_HTML" id="MO2"/></fig></p>
      <p>The patient had repeated GTCS, and accompanying severe aspiration pneumonia. She needed antibiotics and mechanical ventilator support. Considering the patient&#x2019;s exhausted condition, we and her family chose to perform whole-brain radiation therapy (total 30&#xA0;Gy) but not high-dose chemotherapy or rituximab therapy because the main adverse effect, bone marrow suppression, might be critical for her prognosis. Fever and seizures ceased for two months during and after the radiation therapy; however, she never regained consciousness. The follow-up MRIs revealed the progression of the lesions throughout the whole brain accompanying diffuse brain atrophy (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1g, h</xref>). She died one year after the initial onset of fever. No autopsy was permitted.</p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>Unlike nodular lesions with contrast enhancement of PCNSL [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], MRI findings of LC are generally consistent with diffuse leukoencephalopathy with absent or very faint patchy contrast enhancement, mimicking various white matter disorders [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Therefore, diagnosing LC is a difficult challenge and cannot be accomplished using conventional MRI alone. Pathological examination is crucial for making an accurate diagnosis. Pathological examination should show diffuse infiltration of lymphoma cells in the parenchyma without resulting tissue destruction. Furthermore, lack of contrast enhancement in MRI and no destroyed vessels in the histopathological study are assumed to reflect an intact blood&#x2013;brain barrier [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Previous reports of LC have shown several clinical features of this disease, such as subacute progressive dementia, personality changes, unsteady gait and epileptic seizures [<xref ref-type="bibr" rid="CR5">5</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>]: however, to the best of our knowledge, LC in patients with continuous fever has not been reported to date [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>In the present case, we first suspected NAIM based on findings that were suggestive of an inflammatory disease, such as the existence of autoantibodies with inflammatory CSF changes, multiple non-enhanced brain lesions on MRI and the transient improvement experienced after the initial mPSL treatment. NAIM is characterized as a steroid-responsive encephalopathy associated with nonspecific autoantibodies [<xref ref-type="bibr" rid="CR9">9</xref>]. In steroid-resistant cases of NAIM, the use of IVIG results in a sufficiently good outcome [<xref ref-type="bibr" rid="CR10">10</xref>]. In our case, however, the resistance to the subsequent immunotherapy led us to perform the brain biopsy, from which we were able to make a diagnosis of LC. A transient benefit from the mPSL may be explained by the reduction of the lymphocytotoxic effects.</p>
      <p>Although there are no detectable lesions observed during the first experimental MRI, hyperperfusion lesions present in the basal ganglia, thalamus and brainstem, which were observed during the SPECT, might reflect infiltration of LC, indicating that the continuous fever may be explained by dysfunction of thermoregulation in the hypothalamus.</p>
      <p>The prognosis of LC is generally considered to be poorer than that of PCNSL, and most LC patients are reported as dying within six months of the initial onset [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In contrast, some recent LC cases diagnosed at early stages by pathological examination responded favorably to appropriate treatments [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, early pathological diagnosis should be undertaken in patients suspected of having LC.</p>
      <p>In patients with atypical presentations exhibiting features of NAIM, neoplastic disorders of the brain, especially LC, should be considered. Careful follow-up and timely tissue diagnosis are important to determine specific treatments and interventions.</p>
    </sec>
    <sec id="Sec4">
      <title>Abbreviations</title>
      <p>CSF, cerebrospinal fluid; FLAIR, fluid-attenuated inversion recovery; GTCS, generalized tonic-clonic seizures; IVIG, intravenous immunoglobulin; LC, lymphomatosis cerebri; mPSL, methylprednisolone; MRI, magnetic resonance imaging; NAIM, nonvasculitic autoimmune inflammatory meningoencephalitis; PCNSL, primary central nervous system malignant lymphoma; sIL-2R, soluble interleukin-2 receptor; SPECT, single photon emission computed tomography</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors wish to thank the Elsevier Language Editing for scientific English editing.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>Dr. Murakami has received research funding from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 26860675, 15H01563, the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, the SENSHIN Medical Research Foundation. Dr. Hoshi was supported by grants from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 26461314. Dr. Ugawa was supported by grants from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 22390181, the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan, the Uehara Memorial Foundation and the Novartis Foundation (Japan) for the Promotion of Science.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and material</title>
        <p>Not applicable.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>TM: research project conception, organization, execution and writing of the first draft. KY, MS, AY, KN, MI, OS, YY, YT, YS, HI, KS, YH, AK and HT: research execution, manuscript review and critique. AH and YU: research project organization and execution, manuscript review and critique. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the husband of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Not applicable.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakshi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mazziotta</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Mischel</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Jahan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seligson</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Vinters</surname>
              <given-names>HV</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings</article-title>
          <source>Dement Geriatr Cogn Disor</source>
          <year>1999</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>152</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1159/000017116</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollins</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Kleinschmidt-DeMasters</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Corboy</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Damek</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Filley</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatosis cerebri as a cause of white matter dementia</article-title>
          <source>Human Pathol</source>
          <year>2005</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>282</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2005.01.014</pub-id>
          <pub-id pub-id-type="pmid">15791573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerstner</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Batchelor</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <article-title>Primary central nervous system lymphoma</article-title>
          <source>Arch Neurol</source>
          <year>2010</year>
          <volume>67</volume>
          <issue>3</issue>
          <fpage>291</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1001/archneurol.2010.3</pub-id>
          <pub-id pub-id-type="pmid">20212226</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuker</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nagele</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Korfel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heckl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thiel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bamberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Herrlinger</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients</article-title>
          <source>J Neurooncol</source>
          <year>2005</year>
          <volume>72</volume>
          <issue>2</issue>
          <fpage>169</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-004-3390-7</pub-id>
          <pub-id pub-id-type="pmid">15925998</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamate</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ikawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yoneda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arishima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kikuta</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatosis cerebri: clinical characteristics, neuroimaging, and pathological findings</article-title>
          <source>Brain Tumor Pathol</source>
          <year>2012</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>47</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1007/s10014-011-0064-y</pub-id>
          <pub-id pub-id-type="pmid">21927864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tinelli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Antonelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Canevelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fiorelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bozzao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Di Piero</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Caramia</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>MRI findings in lymphomatosis cerebri: description of a case and revision of the literature</article-title>
          <source>J Neuroimaging</source>
          <year>2011</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>e183</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1552-6569.2010.00477.x</pub-id>
          <pub-id pub-id-type="pmid">20345746</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vital</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sibon</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A 64-year-old woman with progressive dementia and leukoencephalopathy</article-title>
          <source>Brain Pathol</source>
          <year>2007</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>117</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1750-3639.2007.00044_2.x</pub-id>
          <pub-id pub-id-type="pmid">17493046</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deutsch</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Mendez</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia</article-title>
          <source>Cogn Behav Neurol</source>
          <year>2015</year>
          <volume>28</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1097/WNN.0000000000000048</pub-id>
          <pub-id pub-id-type="pmid">25812125</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caselli</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Boeve</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Scheithauer</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>O'Duffy</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hunder</surname>
              <given-names>GG</given-names>
            </name>
          </person-group>
          <article-title>Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy</article-title>
          <source>Neurology</source>
          <year>1999</year>
          <volume>53</volume>
          <issue>7</issue>
          <fpage>1579</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.53.7.1579</pub-id>
          <pub-id pub-id-type="pmid">10534272</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imperiale</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Guastamacchia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Duca</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Appendino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Marietti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Romito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Atzori</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Buffa</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Regression of white matter MRI abnormalities in nonvasculitic autoimmune inflammatory meningoencephalitis following intravenous immunoglobulin</article-title>
          <source>Eur Neurol</source>
          <year>2007</year>
          <volume>57</volume>
          <issue>4</issue>
          <fpage>244</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1159/000101291</pub-id>
          <pub-id pub-id-type="pmid">17389804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Courtois</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gille</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haven</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hantson</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy</article-title>
          <source>Case Rep Neurol</source>
          <year>2012</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>181</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1159/000343947</pub-id>
          <pub-id pub-id-type="pmid">23185172</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Satoi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Remission of lymphomatosis cerebri induced by corticosteroid and high-doses intravenous methotrexate</article-title>
          <source>Rinsho Shinkeigaku</source>
          <year>2012</year>
          <volume>52</volume>
          <issue>7</issue>
          <fpage>486</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.5692/clinicalneurol.52.486</pub-id>
          <pub-id pub-id-type="pmid">22849990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davagnanam</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cockerell</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Patani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chataway</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2015</year>
          <volume>86</volume>
          <issue>2</issue>
          <fpage>238</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp-2013-307327</pub-id>
          <pub-id pub-id-type="pmid">24847165</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
